AI assistant
Sending…
Applied Therapeutics, Inc. — Director's Dealing 2019
Jun 5, 2019
34263_dirs_2019-06-05_7fa46739-99c4-41ab-83b8-43e4575daab8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2019-06-03
Reporting Person: Funtleyder Leslie D. (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-06-03 | Stock Option (right to buy) | $10.02 | A | 20460 | Acquired | 2029-06-02 | Common Stock (20460) | Direct |
Footnotes
F1: One thirty-sixth (1/36th) of the shares subject to the Option shall vest each month commencing on July 3, 2019, subject to the Reporting Person continuing to provide service through each such date.
More from Applied Therapeutics, Inc.
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 3
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 3
Delisting Announcement
2026
Feb 3
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3